Area of research
Hematology · Genetics
Research interest
Research interests include Hemophilia Treatment and Research, Blood Coagulation and Thrombosis Mechanisms, Platelet Disorders and Treatments, and Myeloproliferative Neoplasms: Diagnosis and Treatment.
Completion of phase 2b trial of etranacogene dezaparvovec gene therapy in patients with hemophilia B over 5 years
Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohort
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B
Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A
Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A
Postpartum hemorrhage in Sub-Saharan Africa—a prospective study in metropolitan Mozambique
Stable and durable factor IX levels in patients with hemophilia B over 3 years after etranacogene dezaparvovec gene therapy
BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression
Maternal death and postpartum hemorrhage in sub‐Saharan Africa – A pilot study in metropolitan Mozambique
Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B
A cross-sectional analysis of cardiovascular disease in the hemophilia population
Ledipasvir–sofosbuvir and sofosbuvir plus ribavirin in patients with chronic hepatitis C and bleeding disorders
Advances and challenges in hemophilic arthropathy
Vascular remodeling underlies rebleeding in hemophilic arthropathy
Point‐of‐care musculoskeletal ultrasound is critical for the diagnosis of hemarthroses, inflammation and soft tissue abnormalities in adult patients with painful haemophilic arthropathy
Rapid musculoskeletal ultrasound for painful episodes in adult haemophilia patients
Prevalence and Risk Factors for Hypertension in Hemophilia